Buck Institute
People in the News at Myriad Genetics, Twist Bioscience, Day Zero Diagnostics, Genomics England, More
Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of Oct. 2, 2023.
Aelan Licenses Buck Institute Patent Covering Alzheimer's Disease Biomarker
The patent is based on the work of Aelan's founder and covers an epigenetic biomarker associated with DNA damage, cellular senescence, and aging.
Alzheimer's-Related ApoE4 Acts as Transcription Factor to Lead to Disease
A team led by Buck Institute for Research on Aging scientists has reported that ApoE4 binds the promoter regions of Alzheimer's disease genes, including SirT1.
Proteome Sciences, Buck Institute Partner on Test for Breast Cancer Treatment Response
The partners will co-develop mass spectrometry-based tests to predict patient response to therapies such as tamoxifen.
A recent protein interaction study revealed that invertebrates have more in common with humans when it comes to the aging process than had been previously known, and that "the broad patterns underlying genetic control of life span in invertebrates is highly relevant to human aging and longevity."